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Abstract
RNA interference via exogenous short interference RNAs (siRNA) is increasingly more widely employed as a tool in gene
function studies, drug target discovery and disease treatment. Currently there is a strong need for rational siRNA design to
achieve more reliable and specific gene silencing; and to keep up with the increasing needs for a wider range of
applications. While progress has been made in the ability to design siRNAs with specific targets, we are clearly at an infancy
stage towards achieving rational design of siRNAs with high efficacy. Among the many obstacles to overcome, lack of
general understanding of what sequence features of siRNAs may affect their silencing efficacy and of large-scale
homogeneous data needed to carry out such association analyses represents two challenges. To address these issues, we
investigated a feature-selection based in-silico siRNA design from a novel cross-platform data integration perspective. An
integration analysis of 4,482 siRNAs from ten meta-datasets was conducted for ranking siRNA features, according to their
possible importance to the silencing efficacy of siRNAs across heterogeneous data sources. Our ranking analysis revealed for
the first time the most relevant features based on cross-platform experiments, which compares favorably with the
traditional in-silico siRNA feature screening based on the small samples of individual platform data. We believe that our
feature ranking analysis can offer more creditable suggestions to help improving the design of siRNA with specific silencing
targets. Data and scripts are available at http://csbl.bmb.uga.edu/publications/materials/qiliu/siRNA.html.
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Introduction
RNA interference (RNAi) is a gene silencing phenomenon
mediated by a short interfering RNA (siRNA) which comes from a
double-stranded RNA (dsRNA). The RNAi process is to introduce
a siRNA into the cytoplasm, where the guide strand of the siRNA
is incorporated into the RNA-induced silencing complex (RISC).
As RISC binds with the target mRNA, the guide strand of the
siRNA pairs up with the complementary mRNA sequence, leading
to post-transcriptional gene silencing [1,2]. The silencing effect of
RNAi on specific genes makes it a powerful tool in gene function
studies, drug target discovery and disease treatment [3–7].
The efficacy of different siRNAs may vary widely due to the
specific characteristics of the siRNA sequences [8]. Considerable
efforts have been made to study the silencing effects of siRNAs,
and a number of features have been previously identified, which
may affect the efficacy of a siRNA such as GC content, position-
dependent nucleotide composition and the symmetric 39 TT
overhangs [9–12]. More recent studies have proposed a number of
new rules, derived by employing more sophisticated statistical and
machine learning methods as well as based on improved
understanding about the RNA silencing mechanism [11,13–18].
However, these empirical rules were often not discriminative
enough between highly efficacious and inefficacious siRNAs [19]
when tested on independent data. A key issue is that the proposed
rules were generally not derived from a comprehensive dataset
that covers the silencing effects by different siRNAs, which has led
to poor performance by the existing siRNA design tools as
reported in the literature. For instance, Saetrom et al. claimed that
the sequence information alone can determine the efficacy of
siRNAs [10] while several other groups suggested that thermody-
namic features are important to siRNAs effectiveness (a compre-
hensive list of different concerns on related features in siRNA
design is provided in the RESULTS section).
A number of RNAi datasets are publicly available but each
dataset was typically generated by a different group possibly using
a different platform under specific experimental conditions,
making integrated analysis and utilization of these datasets a
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challenge. For example, a variety of assays/platforms/scales were
used when measuring and assessing the siRNA efficacy, such as
different cell types (Hela, fibroblasts), test methods (Western
Blotting, real-time PCR) or siRNA delivery methods (vectors
method, synthetic oligos method). In addition, very different
concentrations of siRNAs might have been used in different
experiments. We observed from our own previous study that
generally the siRNA efficacy for different platforms cannot be
easily compared, hence making a simple integration of heteroge-
neous datasets hardly useful [20].
To address these issues, an effective integration strategy is
needed, which should maximally utilize information from different
datasets to provide a reliable association analysis between features
and the siRNA efficacy than analyses based on any specific dataset
as done in the previous studies. All these require us to re-consider
the current in-silico siRNA design strategies and rectify several
confounding and potentially conflicting viewpoints on specific
features related to siRNA design.
In this study, the features important to siRNA designs across
different datasets were identified, including compositional, ther-
modynamic and structural features of siRNAs. Joint feature
ranking was achieved by integration of feature selections using
three learning methods, namely the L1,2-norm regularization,
L1,?-norm regularization and trace norm regularization [21,22]
on ten meta-datasets. Three ranked feature lists based on the three
methods were integrated into one final ranking list. Our prediction
results show an improved performance over the existing ones in
terms of the silencing efficacy of the designed siRNAs.
Methods
Data sets
Ten siRNA efficacy datasets [17] were used in this study. The
datasets were limited to siRNA sequences targeted at mammalian
mRNAs. By convention, siRNA sequences were represented as
anti-sense sequences from 59 to 39 and the siRNA potency was
measured by the mRNA/protein product levels after gene
silencing. Klingelhoefer et al. [17] noticed the heterogeneous
nature of the ten datasets, and tried to combine the datasets into
one through rescaling the data. However, this simple integration
strategy has hardly led to satisfactory performance [20]. Never-
theless, the meta-datasets curated by Klingelhoefer et al. [17]
provided a good starting point for us to carry out a comprehensive
analysis on feature selection needed for siRNA design.
A detailed description of the ten datasets is presented in Table 1.
Note that the siRecord data [23] was excluded from our study
considering that the data used categorical values, unlike contin-
uous values used in the other datasets when measuring the siRNA
potency. The remaining datasets contain nearly all the RNAi data
using numerical siRNA efficacy values reported so far. In total the
datasets contain 4,482 unique and experimentally validated 19 nt
siRNAs along with their efficacy values. All the datasets can be
downloaded from the Supplementary Information.
The same 497 features proposed by Klingelhoefer et al. [17]
were adopted as the starting point of our study, including
compositional, thermodynamic and structural features. The
compositional features describe the occurrence of certain nucle-
otides at certain positions of the aligned siRNA sequences,
including position-dependent nucleotide preference, GC content,
presence of specific 2-, 3- and 4-mer sequence motifs, presence of
the motifs that stimulate innate immune response and presence of
palindromes. Thermodynamic features cover the binding free
energies and stabilities of the folded structures; and structural
features include secondary structure content. These features cover
the vast majority of the features reported in recent studies, and
provided a comprehensive starting feature set for our study. It
should be noted that the features of the target mRNA do have
important implications on siRNA potency [15,24], however we
did not take them into consideration in this study simply due to
that we just keep the same feature set as proposed by Klingelhoefer
et al. [17] for comparison purpose. The 497 features were listed in
Table S1 for reference.
Computational strategies for feature selection
Data integration and feature selection were carried out by
applying a linear regression model on data generated using three
learning strategies. It exploits possible synergies across different
datasets rather than combines them directly, to learn a predictor
for siRNA efficacy. This predictor allows different regression tasks
to enhance each other during the training process, which
eventually makes the efficacy prediction and the selected features
more reliable than when the datasets are used separately. Three
regularization methods were used, namely, L1,2-norm regulariza-
tion, L1,?-norm regularization and trace norm regularization
[21,22] to provide different constraints during model construction.
The three methods will give rise to three different ranking lists of
features for siRNA design, which will be then integrated to give
one final rankling list. Figure 1 gives an outline of the whole
procedure of our approach while the details of each step are given
in the following subsections.
Algorithms
Multi-Task Learning and Norm Regularization. For a
given set of siRNAs represented as a set of feature vectors,
traditional siRNA model is focused on a specific individual dataset
to learn a regression model for the efficacy prediction. In our
study, we aim at learning a joint efficacy prediction model for all
the given datasets simultaneously, so a multi-task learning
procedure is applied here. Under this framework, a ‘‘Task’’
represents an individual dataset used for the regression model for
siRNA efficacy prediction. The goal of such multi-task learning
model is to learn a set of sparse functions across all the tasks, by
exploiting the possible synergies across different datasets rather
than use only one dataset or combines them directly.
Specifically, the given datasets contain N tuples (the number of
siRNA efficacy data is N), (zi~xi,yi,ki) for i~f1:::Ng, where
xi[Rd is a feature vector containing d features for description for a
specific siRNA, yiis the corresponding efficacy value, and
ki[f1:::Mg is the indicator specifying to which of the M tasks
the example (xi,yi)corresponds. The square loss:
l(z,W )~(y{wTk
:x)2was adopted to learn the regression models,
whereW is a combination of the weight vector for each regression
model which refers to W~½w1,w2,:::,wM [Rd|M for M tasks and
the j-th row ofW is denoted asWj[R1|M , corresponding to the i-
th feature in all M tasks. W is enforced to be sparse to achieve the
goal of cross-platform feature selection. In a sparse multi-task
learning, joint sparsity across different tasks is obtained by adding
the norm of the matrix W to the loss function, which leads to only
a few non-zero rows of W , representing the leading features for
cross-platform siRNA efficacy prediction. Overall, such a joint
multi-task regression problem was formulated as the following
optimization function to solve for W :
min
W
1
2
XN
i~1
l(zi,W )zy(W )
( )
ð1Þ
where y(W )corresponds to the norm function. Note that the three
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different norm forms, i.e., DDW DD1,2 (L1,2-norm), DDW DD1,? (L1,?-
norm) and DDW DD (Trace norm) are used respectively. The
definition of each norm is defined as:
DDW DD1, 2~
Xd
j~1
DDWj DD ð2Þ
DDW DD1,?~
Xd
j~1
DDWj DD?~
Xd
j~1
max
1ƒkƒM
DWjk D ð3Þ
DDW DD~trace(
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
WTW
p
) ð4Þ
The optimization problems resulting from the above sparse
learning formulations were solved using the SLEP (Sparse
Learning with Efficient Projections) package [22], by using
Nesterov’s method and the accelerated gradient method. Detailed
information can be found in [22].
The reason for using three different norms rather than only one
specific norm is explained below: at first, the common character-
istic of all these regularized functions is that it encourages multiple
tasks to share similar sparsity patterns. BasicallyL1,2-norm and
L1,?-norm belong to the L1,q-norm regularization(qw1), which
Table 1. Data description for ten siRNA datasets.
ID Dataset Size Source siRNA sequence Concentration
1 Novartis’s data 2431 Huesken, et al., 2005 antisence 50 nM
2 Jagla’s data 601 Jagla, et al., 2005 antisence 100 nM
3 Katoh’s data 702 Katoh and Suzuki, 2007 sense 10/25 nM
4 Amgen-Dharmacon 239 Reynolds, et al., 2004 antisence 100 nM
5 Harborth’data 42 Harborth, et al., 2003 antisence 100 nM
6 Hsieh’s data 108 Hsieh, et al., 2004 antisence 100 nM
7 Khvorova’s data 10 Khvorova, et al., 2003 antisence 100 nM
8 Vickers’data 76 Vickers, et al., 2003 antisence 100 nM
9 Ui-Tei’s data 50 Ui-Tei, et al., 2004 antisence 50 nM
10 Amarzguioui’s data 223 Amarzguioui and Prydz, 2004 sense 25 nM
doi:10.1371/journal.pone.0037879.t001
Figure 1. The computational framework for integrated cross-platform feature selection in siRNA design.
doi:10.1371/journal.pone.0037879.g001
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contributes to representation sparsity, while trace-norm contrib-
utes to the matrix rank minimization. However, although each of
the three norms can make sparse models in the siRNA efficacy
regression, their induced levels of sparsity are unclear; and which
norm should be applied for a specific case still remains an open
problem [22]. For this particular reason, three different norms
were adopted, and then integrated into one model to reveal the
most un-biased features associated with the siRNA silencing
efficacy, taking advantage of the integration of multi-view
regularization norms.
Feature selection across multiple predictions. In sparse
multi-task learning, the joint sparsity across different tasks is
achieved by adding the regularization norm of matrix W to the
loss function, thus providing an efficient way to evaluate the joint
feature importance in the siRNA design across multiple platforms.
Based on the parameterW derived from the above three methods,
we obtained bi according to the following equation:
bi~
DDwi DD2
DDW DD2,1
,i~1,:::d: ð5Þ
If bi=0, the i
thfeature is the common feature; otherwise, the ith
feature is not useful to the regression learning across different tasks,
since its regression weights are zeros for all the tasks. The value of
bi indicates the weight of the corresponding feature, providing a
quantitative way to evaluate the importance of individual features
for cross-platform siRNA design.
Rank integration. Rank integration was used to integrate
the three feature lists derived based on three regularization forms
[25]. An objective function is defined to cast the rank integration
through solving an optimization problem:
W(d)~
Xm
i~1
wid(d,Li), ð6Þ
where d is an ordered list of length k~DLi D, wi is the importance
weight associated with list Li, d is a distance function that will be
discussed below, and Li is the i
th ordered list [26–28]. The
intuition herein is to find a ‘‘super’’-list that would be as ‘‘close’’ as
possible to each individually ordered list simultaneously. In other
words, d is calculated to minimize the total distance between d
and Li’s, d
~arg min
Pm
i~1
wid(d,Li). The Kendall distance was
selected here [25] to measure the distance between the ordered
lists; and the Cross-Entropy Monte Carlo (CE) algorithm was
applied to solve for the optimal objective value [25,26].
T-test for feature significance evaluation. One-tailed, two
samples, unequal variance t-tests were used to compare the mean
activity for siRNAs which contain a given feature, with the mean
activity of the remaining siRNA that are without such a feature, to
generate the corresponding p-values for their significances. The
threshold was set to be 0.05 as usual.
Results
Results of Ranking Integration
Our study is focused on an improved feature selection strategy
for in-silico siRNA design based on cross-platform data integra-
tion. There are two main issues left to be addressed based on such
an integrated study: (1) how to present an efficient data integration
and feature selection model for siRNA design taking advantages of
the largely distributed experimental siRNA data; and (2) how to
rank these features to uncover their different contributions for
screening highly efficient and specific siRNA as well as to rectify
several confounding and conflicting viewpoints on specific features
related to the current siRNA design. The computational
procedure for addressing these problems is listed in Figure 1.
Specifically, we ran our feature selection algorithm using three
regression models. For each model, we used 10-fold cross-
validation (CV) to conduct feature selection and test the prediction
performance of the model. We selected the overlapping features
across 10-fold CV to form a feature list in which features were
ranked by their weight, and the predictive accuracy was evaluated
by the average RMSEs shown in Table 2. It can be seen that the
performance of the three models gave rise to nearly the same
results, and the L1,2-norm model is slightly superior to the other
two. After the above procedure, we obtained three feature ranking
lists from the regularization forms and the overlap 31 features were
used to be aggregated. Rank integration was applied to obtain the
final rank of the 31 features. Figure 2 shows a visual representation
of the aggregation results. From the top plot, we can see that the
performance stabilizes after roughly 100 iterations, implying the
ranking result is convergent and will not change significantly
anymore. In addition, the bottom plot clearly shows why the
aggregation makes sense, on which the three light-gray lines
represent the input lists, the red line represents the obtained
solution to the optimization problem of ranking aggregation and
the dark grey line represents the integrated optional average
ranking list. Among them, the dark grey line and the red line fit
quite well, indicating the CE algorithm successfully performs and
achieve a satisfying result. It can also be seen that features ranked
high in the final list usually belong to the lists as indicated by
multiple intersecting lines.
To identify whether the selected features are significantly
preferred or avoided for efficient siRNAs, the correlation between
the feature and the siRNA efficacy (product level variable) and p-
values were calculated on dataset 1–4 and 10, respectively, as they
have sufficient data to assure the sample sizes. Table 3 presents the
correlation between the value of each feature and its siRNA
efficacy, as well as the p-value for the significance of the feature.
We also divided the features based on their feature categories (See
Table S14 to Table S16) and rank them according to the
correlation coefficients (R) respectively.
Identified features
The following provides a discussion about the top features
identified through the above analyses and a detailed comparison
between our results with those from Klingelhoefer’s et al. [17],
which were considered representatives of the up-to-date large-
scaled siRNA feature selection, aimed to provide some informa-
tion regarding why they are relevant to siRNA design. It should be
noted that the features discussed here are referred in Table 3 as
rank IDs.
Compositional features. Nucleotide preferences or avoid-
ance are identified at positions 1, 7, 10, 13–14 and 18–19.
Position 1: It was confirmed in our study that nucleotide U and
A are preferable at position 1 (Rank ID: 2, 15) [9,13,14,24,29].
Similar with Klingelhoefer’s results [17], our ranking list also
indicates that U is more preferred than A at this position.
Nucleotide G and C are depleted in the terminal position at the 59
end of the antisense strand (Rank ID: 5, 7).
Position 7: nucleotide C at position 7 (Rank ID: 11) is associated
with a negative effect on the siRNA efficacy, which is consistent
with a few previous studies [9,13,24]. However, this feature was
not found by Klingelhoefer et al [17].
Position 10: having an A at this position was positively
correlated with the siRNA efficacy (Rank ID: 10). This has been
In-Silico siRNA Design Based on Feature Selection
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suggested by numerous previous studies, including Klingelhoefer’s
et al. study [17], and is confirmed by our analysis; and our ranking
also indicates that A has a more positive effect than U at this
position (Rank ID: 27), which can be interpreted by the striking
difference of correlation and p-value.
Positions 13 and 14: our analysis indicates that nucleotide G
should be avoided at both positions (Rank ID: 23, 9). This is
consistent with the observations made by Matveeva et al., Katoh et
al. and Vert et al. [14,24,30], respectively. Klingelhoefer et al. [17]
also reported the negative correlation between G14 and siRNA
potency.
Position 18: In Klingelhoefer’s et al results, nucleotide G at this
position can reduce the siRNA efficacy [17]. However, our
analysis shows that nucleotide A is found to be negatively
correlated with the siRNA efficacy (Rank ID: 25), while nucleotide
C at this position may increase the siRNA efficacy (Rank ID: 20).
To identify the preference or avoidance at position 18, we
carefully searched the previous literature and found our results
Table 2. Accuracy of three regression models for siRNA efficacy prediction.
RMSE
Norm form D1 D2 D3 D4 D5 D6 D7 D8 D9 D10
L1,2-norm 0.1521 0.2359 0.1493 0.2432 0.1062 0.2159 0.0155 0.1938 0.1921 0.2809
L1,?-norm 0.1502 0.2495 0.1584 0.2643 0.0864 0.2318 0.0000 0.2188 0.2893 0.2885
Trace norm 0.1575 0.2503 0.1624 0.2716 0.0813 0.2319 0.0018 0.2028 0.2690 0.2893
doi:10.1371/journal.pone.0037879.t002
Figure 2. A representation of the integrated ranking results.
doi:10.1371/journal.pone.0037879.g002
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Table 3. Feature ranking and correlation coefficients for siRNA design derived from cross-platform data integration.
Rank ID Feat No Feature explanation R p-value Support Opposite
1 414 ‘GGain PS
b[1,2]’
0.3716 0.0000 Lu and Mathews, 2008 [38]; Klingelhoefer et
al., 2009[17];
Matveeva et al., 2007 [14];
Shabalina et al., 2006 [13];
2 40 ‘U @ PS1’ 0.2791 0.0003 Jagla et al., 2005 [29];
Katoh and Suzuki, 2007 [24];
Reynolds et al., 2004 [9];
Shabalina et al., 2006 [13];
Vert et al., 2006 [30];
3 20 ‘A @ PS19’ 20.1443 0.1572 Huesken et al.,2005 [11];
Matveeva et al., 2007 [14];
Shabalina et al., 2006 [13];
4 431 ‘GG in PS[18,19]’ 20.1684 0.1044 Klingelhoefer et al., 2009 [17];
Lu and Mathews, 2008 [38];
Matveeva et al., 2007 [14];
Shabalina et al., 2006 [13];
5 21 ‘G @ PS1’ 20.2137 0.0023 Matveeva et al., 2007 [14];
Shabalina et al., 2006 [13];
6 494 ‘GC content,0.55’ 0.2441 0.0038 Matveeva et al., 2007 [14];
Chalk et al., 2004 [35];
7 59 ‘C @ PS1’ 20.1836 0.0075 Matveeva et al., 2007 [14];
Shabalina et al., 2006 [13];
8 77 ‘C @ PS19’ 0.1120 0.2283 Huesken et al.,2005 [11];
Jagla et al., 2005 [29];
Katoh and Suzuki, 2007 [24];
Matveeva et al., 2007 [14];
Shabalina et al., 2006 [13];
9 34 ‘G @ PS14’ 20.1366 0.0876 Matveeva et al., 2007 [14];
Chalk et al., 2004 [35];
10 11 ‘A @ PS10’ 0.1374 0.0288 Huesken et al.,2005 [11];
Jagla et al., 2005 [29];
Katoh and Suzuki, 2007 [24];
Matveeva et al., 2007 [14];
Reynolds et al., 2004 [9];
Vert et al., 2006 [30];
11 65 ‘C @ PS7’ 20.1264 0.0743 Katoh and Suzuki, 2007 [24];
Reynolds et al., 2004 [9];
Shabalina et al., 2006 [13];
12 491 ‘GC content,0.7’ 0.2408 0.0024 Elbashir et al., [39];
13 492 ‘GC content,0.65’ 0.2436 0.0043
14 493 ‘GC content,0.6’ 0.2444 0.0170 Wang et al., 2004 [40];
15 2 ‘A @ PS1’ 0.1269 0.1147 Jagla et al., 2005 [29];
Katoh and Suzuki, 2007 [24];
Matveeva et al., 2007 [14];
Reynolds et al., 2004 [9];
Shabalina et al., 2006 [13];
16 39 ‘G @ PS19’ 0.0675 0.1340 Jagla et al., 2005 [29];
Katoh and Suzuki, 2007 [24];
Matveeva et al., 2007 [14];
17 125 ‘GCC in PS[1..19]’ 20.1272 0.2189 Klingelhoefer et al., 2009 [17];
In-Silico siRNA Design Based on Feature Selection
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have been proposed by Matveeva et al. and Shabalina et al., for
A18 and C18 respectively.
Position 19: nucleotides C and G are preferable at this position
(Rank ID: 8, 16). Meanwhile, A’s undesirability (Rank ID: 3) is
consistent with Klingelhoefer’s et al suggestion [17].
The connection between the GC content and the siRNA
efficacy is focused by a few research groups [9,14,31–34]. It has
been argued that a high GC content may be a negative
determinant of the functionality of a siRNA, inhibiting the
dissociation of the duplex, which is necessary for RISC loading.
Several published studies indicated that a very low GC content is
also associated with the decreased functionality, presumably due to
the lowered target affinity and specificity of the siRNA [33,35].
However, how to quantitatively describe such association between
the GC content and the siRNA functionality remains unclear. To
address this issue, we investigated five GC content thresholds
potentially important to siRNA efficacy, i.e., GC content,0.55,
GC content,0.7, GC content,0.65, GC content,0.6 and GC
content.0.45 (Rank ID: 6, 12, 13, 14, 24). As ‘GC content,0.55’
ranks much higher than the other three upper limits, we infer the
proper upper-bound of GC content to be around 0.55. It is
somewhat surprising that the lower bound has a negative
correlation, which may be due to the inefficient siRNAs with
high GC content (higher than 0.55). To confirm the speculation
and identify the lower limit of GC content, we discard the siRNA
data which have a GC content higher than 0.55 and selected those
siRNAs with GC contents in the range of 45–55%, 40–55%, …,
5–55% with setting the GC content at an interval of 0.5 (the
lower/higher thresholds are between 5–45%/55–95%, details
showed in Supplementary Material). Statistical analysis indicated
that when the lower limit is 25%, 51.7% of the siRNAs with GC
content in the range of 25–55% are potent for a product level
threshold of 0.3, which is the largest percentage among the
candidate lower limits. Our analysis therefore infers that siRNA
sequences with GC content in the range of 25–55% have an
increased potency. This is similar with the range of GC content
proposed by Reynolds et al. and Matveeva et al. [14] but differs
from the GC content windows come from Klingelhoefer’s et al.
[17]. We also found that when the GC contents are in the range of
35–70% and 35–75% similar to the GC content 35–73% reported
by Klingelhoefer’s et al. [17], only 43.5% and 42.2% of the
siRNAs are potent respectively.
Motif features. Four motifs: ‘CUU’ (Rank ID: 18), ‘CU’
(Rank ID: 19), ‘UCU’ (Rank ID: 26), ‘GUU’ (Rank ID: 31), are
found to increase the siRNA efficacy. It is surprising that a new
motif ‘UCU’ was identified, which has escaped the previous
studies until its detection by Klingelhoefer et al. [17]. Further-
more, our analysis indicates that ‘UCU’ has a positive correlation
with the siRNA efficacy, which is in accordance with the result of
Klingelhoefer et al. [17]. Among the 4,482 siRNA sequences in
our datasets, ‘UCU’ was found to occur in 1,345 sequences and
53% of these siRNAs were potent with product levels ,0.3. We
also made the detailed breakdown of the motif’s occurrences by
position in the siRNA sequence, which can be found in Tables
S2to Table S13.
When looking for position-specific effects of ‘UCU’, they
revealed that siRNAs with high potency always contain the
‘UCU’ motif at either end of the anti-sense sequence, which is
accordant with Klingelhoefer’s finding [17]. However, we
observed a remarkable frequency drop for siRNAs with the motif
at positions 6–8 and position 10–12 (Table S2) while Klingelhoe-
fer’s et al. [17] observed the drop at position 10–12 and position
11–13. We think our observation is more convincing since when
analyzing the motif’s occurrences at each position, we not only
took into account the percentage of a certain motif at a specific
position of potent siRNAs against of all siRNAs, but also
considered the different percentage of a certain motif in different
positions of potent siRNAs. From our point of view, the motif
frequency drop at position 6–8 suggests the avoidance of ‘C’ at
position 7 and the drop at position 10–12 may demonstrate that
potent siRNAs prefer an ‘A’ at position 10, the cleavage site.
Table 3. Cont.
Rank ID Feat No Feature explanation R p-value Support Opposite
18 152 ‘CUU in PS[1..19]’ 0.1420 0.0673 Vert et al., 2006
[30];
19 92 ‘CU in PS[1..19]’ 0.1260 0.2946
20 76 ‘C @ PS18’ 0.0705 0.2627 Shabalina et al., 2006 [13];
21 157 ‘CCC in PS[1..19]’ 20.0856 0.2423 Vert et al., 2006 [30];
22 117 ‘GGC in PS[1..19]’ 20.1259 0.1330
23 33 ‘G @ PS13’ 20.1174 0.1282 Matveeva et al., 2007 [14];
24 485 ‘GC content.0.45’ 20.1719 0.0388
25 19 ‘A @ PS18’ 20.0867 0.2145 Matveeva et al., 2007 [14];
26 140 ‘UCU in PS[1..19]’ 0.1395 0.0562 Klingelhoefer et al., 2009 [17];
27 49 ‘U @ PS10’ 0.0064 0.4615 Jagla et al., 2005 [29];
Katoh and Suzuki, 2007 [24];
28 155 ‘CCG in PS[1..19]’ 20.1352 0.1027 Vert et al., 2006 [30];
29 115 ‘GGG in PS[1..19]’ 20.1561 0.0092
30 471 ‘G stretch of length .= 3’ 20.1561 0.0092
31 120 GUU in PS[1..19]’ 0.0362 0.3726 Vert et al., 2006
[30];
aGG denotes the thermodynamic stability of dinucleotides in siRNA antisense strand.
bPS denotes the position of nucleotides in the siRNA sequence.
doi:10.1371/journal.pone.0037879.t003
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Therefore it can be noted that in our study, the positive
correlation found between ‘UCU’ and silencing efficacy is likely to
reflect a compositional characteristic of the sequences containing
the specific motif. This is partly inconsistent with the conclusion of
Klingelhoefer et al. [17].
Motif ‘CCG’, which was selected by our model, seems to relate
with the motif ‘UCCG’ reported to increase siRNA efficacy by
Klingelhoefer et al. [17] since both motifs contain ‘CCG’ but with
opposite effect on siRNA efficacy. Of 820 siRNAs containing motif
‘CCG’, only 239 appear to be potent. Nevertheless, the position-
specific analysis shows that when ‘CCG’ occurs at position 4–6,
14–16 and 16–18, it leads an increase of siRNA efficacy (Table
S5). We also conduct a position-specific analysis on motif ‘UCCG’
to find some relations between ‘UCCG’ and ‘CCG’. Interestingly,
we found that potent siRNAs share an enrichment of motif
‘UCCG’ at position 3–6, 7–10 and 15–18 (Table S7), which can
explain the occurrence of ‘CCG’ at position 4–6 and 16–18 and
indicates a ‘U’ in position 7.
Five motifs: ‘GCC’ (Rank ID: 17), ‘CCC’ (Rank ID: 21), ‘GGC’
(Rank ID: 22), ‘CCG’ (Rank ID: 28) and ‘GGG’ (Rank ID: 29) are
found to be negatively correlated with the siRNA potency, among
which ‘GCC’ has also been pointed out by Klingelhoefer et al.
[17] while ‘CUU’ and ‘GUU’ were contrary to the results of Vert
et al. [30]. It can be seen from Table 3 that motif ‘CUU’ has a
remarkable positive correlation coefficient with p-value ,0.1,
tends to be positively affect siRNA efficacy. In the later position-
specific analysis, we found a sharply frequency drop of motif
‘CUU’ at position 7–10 in potent siRNAs, indicating the
avoidance of ‘C’ at position 7 once more (Table S8). We inferred
that the contradiction between our result and that of Vert’s et al.
[30] may be caused by the difference of dataset. In Vert’s study
[30], they only used Novartis’s data to select the features and
inevitably missed some important information from other datasets.
Unlike motif ‘CUU’, although motif ‘GUU’ is represented in
our feature list, this feature was not found to be significantly
correlated with siRNA efficiency. The three 4-mer motifs selected
by Klingelhoefer et al. [17] were not selected by our algorithm as
well, which may due to comparative lack of data.In addition, motif
‘GGG’, along with the feature ‘G stretch of length .=3’, suggest
that continuous nucleotide ‘G’ should be removed in siRNA
design, especially at position 1–3 and 17–19 after analyzing their
position-specific effects (Table S13).
Thermodynamic features. Half of the top-4 features are
thermodynamic features, indicating the critical role of the
thermodynamic properties of a siRNA in duplex unwinding and
strand retention by the complex [9,36]. It is generally believed that
siRNAs with high efficacy tend to have more instable 59-ends in
their antisense strands [9,13–15]. Previous studies have found a
strong correlation between the siRNA efficacy and the thermo-
dynamic stability of dinucleotides (GG), especially for the first
(GG1–2, Rank ID: 1) and the last (GG18–19, Rank ID: 4)
dinucleotides on the siRNA antisense strand, which is consistent
with our observation. Besides, GG1–4 and GG13–14 which were
suggested by Klingelhoefer et al. [17] have not been selected by
our models. Although GG13–14 was not in our result, two
compositional features, nucleotide G in position13 and 14 also
implied the positive effect of GG13–14 in potent siRNAs.
Validation of selected features
We believed that in-vivo experimental studies on specific
mutations in siRNAs will help to validate some of the identified
features. Nevertheless, as a computational study, we can validate
the selected features in-silico. In order to compare the features
with other proposed ones, a linear ridge regression model was
trained using 31 identified features on each of the 10 datasets for
siRNA efficacy prediction to check the performance. We used
1,000 rounds of 2-fold cross-validation to train each model and test
it. The average Root Mean Square Error (RMSE) was calculated
for each experiment. Then linear regression models were
constructed using 19 features reported by Klingelhoefer et al.
[17] through 1,000 rounds of cross-validation, which will be served
as the comparison. From Table 4, we can see that the prediction
model with our feature set outperformed those from Klingelhoefer
et al. [17] in 7 out of 10 datasets. For the smallest dataset (Dataset
7), model trained with Klingelhoefer’s feature set [17] obviously
gave rise to a better performance than that with our feature set.
The poor performance of this experiment may result from the
limited training samples, and such samples may lack of the most of
the 31 selected features. When excluding the results of Dataset 7,
the p-value for one-tailed pair t-test is 0.1, indicating that our
prediction results are statistically significantly superior to those of
Klingelhoefer’s et al [17].
Discussion
In this study, a joint feature selection across multiple siRNA-
efficacy datasets was conducted. Three norm regularization
methods were employed to exploit the feature space for siRNA
design, which prevented the deviation resulted from using only one
method, thus making the selected features more reliable and
useful. The rank integration method was applied to obtain a more
effective list of 31 features, which all have more significant
correlations and p-values than the lower ranked ones.
We succeeded in confirming the majority of the previously
reported features in silico, rectifying several conflicting rules as well
as identifying several novel features.
Generally, siRNAs with high potency prefer to contain A or U
towards the 59 ends and G or C towards the 39 ends of their guide
strands. It should be noted that the p-values of some identified
features, like G and C at the 39 ends, are larger than 0.1. This can be
explained by the fact that almost all the siRNAs are designed to have
G or C at the 39 ends on their antisense strand, no matter whether
the siRNA is efficient or not. In the middle of the guide strands, the
requirement of an A is related to the previously characterized A-
Table 4. Comparison between the model with 31 identified features (31_Feat) and the model with Klingelhoefer’s et al. 19
features (19_Feat) for siRNA efficacy prediction.
RMSE
D1 D2 D3 D4 D5 D6 D8 D9 D10
31_Feat 0.1557 0.2486 0.1615 0.2650 0.1592 0.2418 0.4474 0.2601 0.2205
19_Feat 0.1641 0.2516 0.1595 0.2662 0.1601 0.2517 0.4161 0.2546 0.2753
doi:10.1371/journal.pone.0037879.t004
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cleavage site [37]. Nucleotide G depleted at positions 13 and 14
corresponds to the duplex stability in these two positions, suggesting
a positive correlation between the free energy of the base pair in
these positions and the siRNA efficiency of silencing.
Motif ‘UCU’ identified by our methods is essential for efficient
RNA interference, which has been discovered as a novel feature by
Klingelhoefer et al. [17]. Failing to identify the role of ‘UCU’ by
previous studies may be caused by the insufficient siRNA efficacy
data. Our analysis suggests that ‘UCU’ is a reliable feature positively
correlated with the siRNA potency because it reflects and
demonstrates the compositional characteristic in potent siRNAs.
By observing the general characteristics of the motifs that
correlate with the increased or decreased potencies, we drew an
opposite conclusion to that by Vert et al. [30], which is that potent
siRNAs still can carry motifs containing C or G at 59 in the
antisense strand as long as they do not appear at specific positions,
such as ‘G/C’ at 59end and ‘C’ at position 7.
The finding that the dinucleotide thermodynamic stability at the
59-end of the siRNA sequence, dG1–2, is more decisive for siRNA
potency than the tetranucleotide stability, dG1–2 is also very
interesting in terms of understanding the mechanism of siRNA
incorporation into the RISC complex. The thermodynamic
stability in the first two base pairs (GG1–2, GG18–19) is a good
indicator of siRNA efficacy and thermodynamic consideration of
four terminal nucleotides provides poorer correlation with siRNA
efficacy which doesn’t appear in our feature list. We infer that the
thermodynamic stability of two base pairs at other positions may
vary greatly even in potent siRNAs.
For the future research, we will include other features such as
the properties of the target mRNAs as well as the matching
properties between mRNAs and miRNAs. Considering the
diversity and heterogeneity of data generated by different research
groups, we strive to find novel methods to deal with the issue
associated with the multiple platform data sources. A novel
method named ‘heterogeneous transfer learning’ for utilizing
siRNA datasets whose marginal distributions and output criteria
are different is under preparation, which is expected to provide
another new way to improve the reliability of the siRNA efficacy
prediction from cross-platform data.
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